Abstract

Aberrant immune activity during neurodevelopment could participate in the generation of neurological dysfunctions characteristic of several neurodevelopmental disorders (NDDs). Numerous epidemiological studies have shown a link between maternal infections and NDDs risk; animal models of maternal immune activation (MIA) have confirmed this association. Activation of maternal immune system during pregnancy induces behavioral and functional alterations in offspring but the biological mechanisms at the basis of these effects are still poorly understood. In this study, we investigated the effects of prenatal lipopolysaccharide (LPS) exposure in peripheral and central inflammation, cortical cytoarchitecture and behavior of offspring (LPS-mice). LPS-mice reported a significant increase in interleukin-1β (IL-1β) serum level, glial fibrillary acidic protein (GFAP)- and ionized calcium-binding adapter molecule 1 (Iba1)-positive cells in the cortex. Furthermore, cytoarchitecture analysis in specific brain areas, showed aberrant alterations in minicolumns’ organization in LPS-mice adult brain. In addition, we demonstrated that LPS-mice presented behavioral alterations throughout life. In order to better understand biological mechanisms whereby LPS induced these alterations, dams were treated with meloxicam. We demonstrated for the first time that exposure to LPS throughout pregnancy induces structural permanent alterations in offspring brain. LPS-mice also present severe behavioral impairments. Preventive treatment with meloxicam reduced inflammation in offspring but did not rescue them from structural and behavioral alterations.

Highlights

  • Neurodevelopmental disorders (NDDs) are a group of disorders associated with impaired brain development

  • We focused our attention on an emerging potential cause of NDDs: maternal immune activation (MIA)

  • We measured in adult mice offspring: (a) IL-1β levels in the serum as a marker of peripheral inflammation by ELISA; (b) ionized calcium-binding adapter molecule 1 (Iba1)- and glial fibrillary acidic protein (GFAP)-positive cells in the cortex by IHC as markers of central inflammation

Read more

Summary

Introduction

Neurodevelopmental disorders (NDDs) are a group of disorders associated with impaired brain development. Developmental brain dysfunctions may first appear in the postnatal period, such as in autism spectrum disorders (ASD) and Down syndrome, or in adulthood as in neuropsychiatric disorders, with emotional, relational and cognitive deficits [1,2,3]. Development of the nervous system is extremely complex and tightly regulated by a series of mechanisms, such as cells proliferation, migration and differentiation, an alteration in one or more of these mechanisms could lead to NDDs [4,5,6]. The origins of NDDs are so varied and heterogeneous that finding a preventive cure for these disorders is currently an extremely demanding challenge. We focused our attention on an emerging potential cause of NDDs: maternal immune activation (MIA). In the last 20 years, several epidemiological studies have shown an association

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call